Design Therapeutics
DSGN
DSGN
79 hedge funds and large institutions have $692M invested in Design Therapeutics in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 10 closing their positions.
Holders
79
Holders Change
+5
Holders Change %
+6.76%
% of All Funds
1.37%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
33
Reduced
18
Closed
10
Calls
$7.91M
Puts
$1.13M
Net Calls
+$6.78M
Net Calls Change
+$4.1M
Top Buyers
| 1 |
1
Janus Henderson Group
London,
United Kingdom
|
$50.3M |
| 2 |
2
Goldman Sachs
New York
|
$16.6M |
| 3 |
RCM
3
RA Capital Management
Boston,
Massachusetts
|
$46.4M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$15.2M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$25.9M |
